Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet | 5 | 2023 | 111 | 1.990 |
Why?
|
| Humans | 50 | 2025 | 6794 | 1.280 |
Why?
|
| Health Status Disparities | 2 | 2021 | 83 | 1.220 |
Why?
|
| African Americans | 7 | 2015 | 264 | 1.110 |
Why?
|
| United States | 17 | 2025 | 1019 | 1.100 |
Why?
|
| Male | 38 | 2025 | 3671 | 1.090 |
Why?
|
| Female | 38 | 2025 | 4060 | 1.040 |
Why?
|
| Adult | 28 | 2023 | 2113 | 1.000 |
Why?
|
| Pandemics | 3 | 2023 | 87 | 1.000 |
Why?
|
| Middle Aged | 26 | 2023 | 2108 | 0.850 |
Why?
|
| Food | 1 | 2023 | 8 | 0.820 |
Why?
|
| Databases, Factual | 5 | 2020 | 81 | 0.800 |
Why?
|
| Nutrition Assessment | 1 | 2023 | 26 | 0.770 |
Why?
|
| Adolescent | 17 | 2025 | 869 | 0.760 |
Why?
|
| Fatty Liver | 2 | 2021 | 59 | 0.750 |
Why?
|
| Accidents, Traffic | 2 | 2020 | 14 | 0.730 |
Why?
|
| Aged | 20 | 2023 | 1539 | 0.730 |
Why?
|
| Mexican Americans | 1 | 2021 | 14 | 0.690 |
Why?
|
| Young Adult | 9 | 2021 | 567 | 0.680 |
Why?
|
| Driving Under the Influence | 1 | 2020 | 1 | 0.640 |
Why?
|
| Stress, Psychological | 3 | 2025 | 60 | 0.620 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 38 | 0.620 |
Why?
|
| Bicycling | 1 | 2019 | 4 | 0.620 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 279 | 0.620 |
Why?
|
| Injury Severity Score | 1 | 2019 | 7 | 0.620 |
Why?
|
| Neck Injuries | 1 | 2019 | 7 | 0.620 |
Why?
|
| Head Protective Devices | 1 | 2019 | 4 | 0.620 |
Why?
|
| Craniocerebral Trauma | 1 | 2019 | 10 | 0.610 |
Why?
|
| Hospital Mortality | 2 | 2019 | 36 | 0.610 |
Why?
|
| Aged, 80 and over | 12 | 2016 | 497 | 0.570 |
Why?
|
| Diabetes Mellitus | 3 | 2016 | 208 | 0.510 |
Why?
|
| Dementia, Vascular | 1 | 2016 | 6 | 0.480 |
Why?
|
| Inpatients | 1 | 2016 | 22 | 0.470 |
Why?
|
| Risk Factors | 9 | 2025 | 767 | 0.470 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 30 | 0.460 |
Why?
|
| Dementia | 1 | 2015 | 14 | 0.450 |
Why?
|
| Puberty | 2 | 2025 | 17 | 0.450 |
Why?
|
| Nutrition Surveys | 5 | 2021 | 67 | 0.440 |
Why?
|
| Pancreatitis | 2 | 2007 | 108 | 0.440 |
Why?
|
| Treatment Outcome | 4 | 2020 | 500 | 0.420 |
Why?
|
| Prevalence | 5 | 2021 | 259 | 0.400 |
Why?
|
| Metabolic Syndrome | 2 | 2020 | 35 | 0.400 |
Why?
|
| Substance-Related Disorders | 2 | 2025 | 102 | 0.390 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 8 | 0.390 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2003 | 25 | 0.380 |
Why?
|
| Child | 9 | 2025 | 524 | 0.360 |
Why?
|
| Immunization | 2 | 2001 | 19 | 0.330 |
Why?
|
| Hospitalization | 4 | 2015 | 128 | 0.320 |
Why?
|
| Retrospective Studies | 7 | 2023 | 681 | 0.290 |
Why?
|
| Comorbidity | 3 | 2016 | 147 | 0.280 |
Why?
|
| Jaundice | 1 | 2007 | 3 | 0.270 |
Why?
|
| Multiple Organ Failure | 1 | 2007 | 8 | 0.270 |
Why?
|
| Healthcare Disparities | 2 | 2023 | 83 | 0.270 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2007 | 65 | 0.270 |
Why?
|
| Albuminuria | 2 | 2020 | 31 | 0.260 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2007 | 2 | 0.260 |
Why?
|
| Proton Pump Inhibitors | 1 | 2007 | 2 | 0.260 |
Why?
|
| Diarrhea | 1 | 2007 | 10 | 0.260 |
Why?
|
| Cross Infection | 1 | 2007 | 12 | 0.260 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2023 | 153 | 0.250 |
Why?
|
| Hepatitis C | 1 | 2006 | 19 | 0.250 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 506 | 0.240 |
Why?
|
| Health Surveys | 3 | 2017 | 75 | 0.240 |
Why?
|
| Underage Drinking | 1 | 2025 | 7 | 0.230 |
Why?
|
| Alcohol Drinking | 1 | 2025 | 65 | 0.220 |
Why?
|
| Los Angeles | 6 | 2010 | 321 | 0.220 |
Why?
|
| Dyspepsia | 1 | 2004 | 2 | 0.210 |
Why?
|
| Regression Analysis | 2 | 2021 | 66 | 0.210 |
Why?
|
| Neurosecretory Systems | 1 | 2024 | 8 | 0.210 |
Why?
|
| Cultural Diversity | 2 | 2019 | 16 | 0.210 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2023 | 4 | 0.210 |
Why?
|
| Chronic Disease | 2 | 2023 | 167 | 0.210 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 9 | 0.200 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2023 | 29 | 0.200 |
Why?
|
| Sex Characteristics | 1 | 2024 | 39 | 0.200 |
Why?
|
| Xylans | 2 | 2016 | 33 | 0.200 |
Why?
|
| Granulomatous Mastitis | 1 | 2023 | 1 | 0.200 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 35 | 0.200 |
Why?
|
| Geriatric Assessment | 1 | 2023 | 13 | 0.200 |
Why?
|
| Eating | 1 | 2023 | 31 | 0.190 |
Why?
|
| Veterans | 1 | 2023 | 70 | 0.190 |
Why?
|
| Exercise | 1 | 2023 | 55 | 0.190 |
Why?
|
| Population Surveillance | 3 | 2017 | 30 | 0.190 |
Why?
|
| Child, Preschool | 8 | 2013 | 258 | 0.190 |
Why?
|
| Minority Groups | 2 | 2019 | 63 | 0.180 |
Why?
|
| Mentoring | 1 | 2021 | 12 | 0.170 |
Why?
|
| Biomedical Research | 2 | 2019 | 34 | 0.170 |
Why?
|
| Small-Area Analysis | 1 | 2001 | 4 | 0.170 |
Why?
|
| Curcumin | 1 | 2020 | 8 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2020 | 10 | 0.170 |
Why?
|
| Physicians | 1 | 2021 | 49 | 0.170 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 36 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 30 | 0.160 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 20 | 0.160 |
Why?
|
| Blood Alcohol Content | 1 | 2020 | 1 | 0.160 |
Why?
|
| Depression | 2 | 2016 | 128 | 0.160 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 72 | 0.160 |
Why?
|
| Age Distribution | 1 | 2020 | 45 | 0.160 |
Why?
|
| Biomarkers | 3 | 2020 | 214 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 280 | 0.160 |
Why?
|
| Trauma Centers | 1 | 2019 | 7 | 0.150 |
Why?
|
| Education | 1 | 2019 | 11 | 0.150 |
Why?
|
| Research Personnel | 1 | 2019 | 9 | 0.150 |
Why?
|
| Urological Agents | 1 | 2019 | 1 | 0.150 |
Why?
|
| Sex Distribution | 2 | 2017 | 44 | 0.150 |
Why?
|
| Erectile Dysfunction | 1 | 2019 | 14 | 0.150 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 64 | 0.150 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 4 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 15 | 0.130 |
Why?
|
| Cognition | 1 | 2017 | 30 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2017 | 74 | 0.130 |
Why?
|
| Viremia | 1 | 2016 | 8 | 0.130 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 4 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2016 | 53 | 0.120 |
Why?
|
| Acute Disease | 2 | 2007 | 91 | 0.120 |
Why?
|
| Odds Ratio | 3 | 2014 | 82 | 0.110 |
Why?
|
| Stroke | 1 | 2016 | 46 | 0.110 |
Why?
|
| Research Design | 3 | 2023 | 41 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2023 | 108 | 0.110 |
Why?
|
| Adolescent Development | 2 | 2025 | 15 | 0.110 |
Why?
|
| Sex Factors | 2 | 2025 | 155 | 0.110 |
Why?
|
| Hypertension | 1 | 2016 | 147 | 0.110 |
Why?
|
| Cartoons as Topic | 1 | 2014 | 1 | 0.110 |
Why?
|
| Shock, Septic | 1 | 2014 | 4 | 0.110 |
Why?
|
| Elective Surgical Procedures | 1 | 2014 | 5 | 0.110 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 6 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2014 | 9 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 58 | 0.100 |
Why?
|
| Diabetes Complications | 1 | 2014 | 41 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2013 | 12 | 0.100 |
Why?
|
| Health Literacy | 1 | 2014 | 35 | 0.100 |
Why?
|
| Hand Injuries | 1 | 1993 | 1 | 0.100 |
Why?
|
| Empathy | 1 | 2013 | 2 | 0.100 |
Why?
|
| Joint Dislocations | 1 | 1993 | 2 | 0.100 |
Why?
|
| California | 5 | 2014 | 230 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 1993 | 21 | 0.100 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2003 | 8 | 0.100 |
Why?
|
| Infant | 5 | 2013 | 187 | 0.090 |
Why?
|
| Health Services Accessibility | 2 | 2011 | 145 | 0.090 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 59 | 0.090 |
Why?
|
| Triazoles | 1 | 2011 | 12 | 0.090 |
Why?
|
| Pyrazines | 1 | 2011 | 17 | 0.090 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 39 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2010 | 34 | 0.080 |
Why?
|
| Sunburn | 1 | 2010 | 1 | 0.080 |
Why?
|
| Sunlight | 1 | 2010 | 1 | 0.080 |
Why?
|
| Parenting | 1 | 2010 | 18 | 0.080 |
Why?
|
| Nicotine | 1 | 2012 | 144 | 0.080 |
Why?
|
| Age Factors | 2 | 2025 | 193 | 0.080 |
Why?
|
| Health Education | 1 | 2010 | 55 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 63 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2007 | 27 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 165 | 0.080 |
Why?
|
| Brucellosis | 1 | 1988 | 1 | 0.070 |
Why?
|
| Muscular Diseases | 1 | 1988 | 5 | 0.070 |
Why?
|
| Bone Diseases | 1 | 1988 | 7 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2023 | 331 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 420 | 0.070 |
Why?
|
| Liver | 2 | 2023 | 157 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2007 | 4 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2007 | 49 | 0.070 |
Why?
|
| Pregnancy | 2 | 2006 | 599 | 0.060 |
Why?
|
| Databases as Topic | 1 | 2007 | 9 | 0.060 |
Why?
|
| Focus Groups | 2 | 2019 | 46 | 0.060 |
Why?
|
| Telephone | 2 | 2010 | 4 | 0.060 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2006 | 2 | 0.060 |
Why?
|
| Colonic Diseases | 1 | 2006 | 3 | 0.060 |
Why?
|
| Program Evaluation | 2 | 2021 | 46 | 0.060 |
Why?
|
| Hypoglycemia | 1 | 2007 | 30 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 73 | 0.060 |
Why?
|
| Colon | 1 | 2006 | 20 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2006 | 17 | 0.060 |
Why?
|
| Adolescent Health Services | 1 | 2006 | 6 | 0.060 |
Why?
|
| Needs Assessment | 1 | 2006 | 16 | 0.060 |
Why?
|
| Child Health Services | 1 | 2006 | 17 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2006 | 32 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2006 | 52 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2006 | 145 | 0.060 |
Why?
|
| Inflammation | 1 | 2006 | 143 | 0.060 |
Why?
|
| Testosterone | 1 | 2025 | 50 | 0.060 |
Why?
|
| Public Housing | 1 | 2005 | 6 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 140 | 0.060 |
Why?
|
| Pregnancy, Ectopic | 1 | 2005 | 6 | 0.060 |
Why?
|
| Adolescent Behavior | 1 | 2025 | 43 | 0.060 |
Why?
|
| Marijuana Use | 1 | 2025 | 9 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 10 | 0.060 |
Why?
|
| Gallstones | 1 | 2004 | 6 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 44 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2004 | 7 | 0.050 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2004 | 28 | 0.050 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2004 | 6 | 0.050 |
Why?
|
| Radiography | 1 | 2004 | 20 | 0.050 |
Why?
|
| Hospitals, Urban | 1 | 2004 | 10 | 0.050 |
Why?
|
| ROC Curve | 1 | 2023 | 28 | 0.050 |
Why?
|
| Biopsy | 1 | 2023 | 36 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 21 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2023 | 34 | 0.050 |
Why?
|
| Food Supply | 1 | 2023 | 11 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2016 | 84 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 58 | 0.050 |
Why?
|
| HIV Infections | 1 | 2007 | 432 | 0.050 |
Why?
|
| Urban Population | 1 | 2003 | 85 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 197 | 0.050 |
Why?
|
| Faculty | 1 | 2021 | 10 | 0.040 |
Why?
|
| Mentors | 1 | 2021 | 19 | 0.040 |
Why?
|
| Quality of Life | 1 | 2023 | 184 | 0.040 |
Why?
|
| Database Management Systems | 1 | 2001 | 10 | 0.040 |
Why?
|
| Sirolimus | 1 | 2020 | 6 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 14 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 27 | 0.040 |
Why?
|
| Base Sequence | 1 | 2020 | 65 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 40 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 24 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2001 | 77 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 12 | 0.040 |
Why?
|
| Logistic Models | 1 | 2001 | 165 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2000 | 11 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2000 | 7 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 156 | 0.040 |
Why?
|
| Vaccines | 1 | 2000 | 10 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 170 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 127 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 88 | 0.040 |
Why?
|
| Vaccination | 1 | 2000 | 49 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2020 | 54 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2020 | 143 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 197 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2013 | 199 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 246 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 15 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 82 | 0.030 |
Why?
|
| Ribavirin | 1 | 2016 | 2 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 23 | 0.030 |
Why?
|
| Viral Load | 1 | 2016 | 26 | 0.030 |
Why?
|
| Oryza | 1 | 2016 | 11 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 48 | 0.030 |
Why?
|
| Video Recording | 1 | 2014 | 7 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 51 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2014 | 82 | 0.030 |
Why?
|
| England | 1 | 1993 | 1 | 0.030 |
Why?
|
| Hospitals, District | 1 | 1993 | 1 | 0.030 |
Why?
|
| Hospitals, General | 1 | 1993 | 1 | 0.030 |
Why?
|
| Finger Injuries | 1 | 1993 | 2 | 0.030 |
Why?
|
| Psychometrics | 1 | 2013 | 14 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2013 | 17 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 197 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 115 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 10 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2012 | 16 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2012 | 21 | 0.020 |
Why?
|
| Animal Feed | 1 | 2012 | 11 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 28 | 0.020 |
Why?
|
| Triglycerides | 1 | 2012 | 58 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2012 | 85 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2012 | 102 | 0.020 |
Why?
|
| Interdisciplinary Studies | 1 | 2011 | 2 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 7 | 0.020 |
Why?
|
| Program Development | 1 | 2011 | 34 | 0.020 |
Why?
|
| Sitagliptin Phosphate | 1 | 2011 | 6 | 0.020 |
Why?
|
| Universities | 1 | 2011 | 21 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 258 | 0.020 |
Why?
|
| Curriculum | 1 | 2011 | 53 | 0.020 |
Why?
|
| Social Class | 1 | 2011 | 46 | 0.020 |
Why?
|
| Apoptosis | 1 | 2012 | 179 | 0.020 |
Why?
|
| Ethiodized Oil | 1 | 2010 | 3 | 0.020 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2010 | 3 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2010 | 3 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2010 | 6 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2010 | 9 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 6 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 23 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 45 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2010 | 101 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 21 | 0.020 |
Why?
|
| Mice | 1 | 2012 | 746 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 89 | 0.020 |
Why?
|
| Ethanol | 1 | 2010 | 86 | 0.020 |
Why?
|
| Health Promotion | 1 | 2010 | 89 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 268 | 0.020 |
Why?
|
| Saudi Arabia | 1 | 1988 | 1 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 1988 | 9 | 0.020 |
Why?
|
| Recurrence | 1 | 1988 | 55 | 0.020 |
Why?
|
| Animals | 1 | 2012 | 1875 | 0.020 |
Why?
|
| Medical Records | 1 | 2007 | 23 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2006 | 10 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2006 | 28 | 0.020 |
Why?
|
| Eyeglasses | 1 | 2006 | 8 | 0.020 |
Why?
|
| Data Collection | 1 | 2005 | 38 | 0.010 |
Why?
|
| Health Status | 1 | 2005 | 83 | 0.010 |
Why?
|